Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 25

Sort by

Sort Order Select

Journal Articles

Immunophenotypic Characteristics of CD34+ Cells According to Genetic Markers in Acute Myeloid Leukemias with Normal Karyotype.

Mauricio A Chandía, MD, Ma Belén Vidriales, MD, PhD, Carmen Chillón, PhD, Marcos González, MD, PhD, Norma Gutiérrez, MD, PhD, Jesús F San Miguel, MD, PhD

Blood (2012) 120 (21): 2554.

https://doi.org/10.1182/blood.V120.21.2554.2554

Published: 2012

Journal Articles

Phenotypic, Functional and Circadian Characterization of Peripheral Blood (PB) Multiple Myeloma (MM) Circulating Tumor Cells (CTCs)

Bruno Paiva, Teresa Paíno, Mercedes Garayoa, Laura San-Segundo, Montserrat Martin, Maria Luz Sanchez, Paloma Barcena, Luis Corchete, Enrique M Ocio, MD, PhD, Maria Victoria Mateos, MD, PhD, María-Belén Vidriales, Alberto Orfao, Jesus F. San Miguel, MD, PhD

Blood (2012) 120 (21): 726.

https://doi.org/10.1182/blood.V120.21.726.726

Published: 2012

Journal Articles

Multiparameter Flow Cytometry (MFC) for Identification of the Waldenström's Clone in IgM MGUS and Waldenstrom's Macroglobulinemia (WM): New Criteria for Differential Diagnosis and Risk Stratification

Bruno Paiva, Maria-Carmen Montes, Ramón García-Sanz, Jennifer Alonso, Natalia de las Heras, Fernando Escalante, Alfonso Garcia de Coca, Josefina Galende, Jose Hernández, Alejandro Martín, Emilia Pardal, Abelardo Bárez, Jose M Alonso, MD, Alberto Orfao, Enrique M Ocio, MD, PhD, María-Belén Vidriales, Jesus F. San Miguel, MD, PhD

Blood (2012) 120 (21): 936.

https://doi.org/10.1182/blood.V120.21.936.936

Published: 2012

Journal Articles

Whole Bone Marrow (BM) Immunophenotypic Profiling for the Identification of Newly Diagnosed Symptomatic Multiple Myeloma (MM) Patients with an MGUS-Like Signature Associated with Long-Term Disease Control (LTDC)

Blood (2012) 120 (21): 3949.

https://doi.org/10.1182/blood.V120.21.3949.3949

Published: 2012

Journal Articles

Multiparameter Flow Cytometry (MFC) Evaluation of Plasma Cell (PC) DNA Ploidy Status and Proliferative Rate in 595 Multiple Myeloma (MM) Patients (pts) Included in the Spanish GEM2000 and GEM2005<65years Trials: Clinical Value and Biological Insights,

Blood (2011) 118 (21): 3938.

https://doi.org/10.1182/blood.V118.21.3938.3938

Published: 2011

Journal Articles

Influence of Lenalidomide Treatment on Immune Effector Cells From High-Risk Smoldering Multiple Myeloma (SMM) Patients,

Bruno Paiva, Maria Victoria Mateos, Lucía López-Corral, María-Belén Vidriales, Miguel T. Hernandez, Joan Bargay, Felipe de Arriba, Javier De La Rubia, Ana-Isabel Teruel, Pilar Giraldo, Laura Rosiñol, MD, Felipe Prosper, MD, Albert Oriol, Jose Hernández, Graça Esteves, Fernando Leal da Costa, Juan José Lahuerta, Joan Blade, Jesus F. San Miguel, MD, PhD

Blood (2011) 118 (21): 3944.

https://doi.org/10.1182/blood.V118.21.3944.3944

Published: 2011

Journal Articles

High-Risk Cytogenetics and Persistent Minimal Residual Disease (MRD) by Multiparameter Flow Cytometry (MFC) Predict Unsustained Complete Response (CR) After Autologous Stem Cell Transplantation (ASCT) in Multiple Myeloma (MM)

Blood (2011) 118 (21): 630.

https://doi.org/10.1182/blood.V118.21.630.630

Published: 2011

Journal Articles

Multidimensional Flow Cytometric (MFC) Analysis of the Immune System of Multiple Myeloma (MM) Patients Achieving Long Term Disease Control

Roberto J. Pessoa Magalhaes, María-Belén Vidriales, Bruno Paiva, Maria-Victoria Mateos, Norma C. Gutierrez, Ramón García-Sanz, Juan F Blanco, Jose Hernández, Natalia de las Heras, Joaquin Martinez, MD, Elaine Sobral Costa, MD, PhD, Angelo Maiolino, MD, PhD, M. Nucci, MD, PhD, Javier De La Rubia, Juan-Jose Lahuerta, MD, Alberto Orfao, MD, PhD, Jesús F. San Miguel, Sr., MD, PhD

Blood (2011) 118 (21): 810.

https://doi.org/10.1182/blood.V118.21.810.810

Published: 2011

Journal Articles

Biological and Clinical Significance of CD81 Expression by Clonal Plasma Cells in High-Risk Smoldering and Symptomatic Multiple Myeloma (MM) Patients,

Blood (2011) 118 (21): 3936.

https://doi.org/10.1182/blood.V118.21.3936.3936

Published: 2011

Journal Articles

Myelodysplasia-Associated Immunophenotypic Abnormalities of Bone Marrow (BM) Cells in Multiple Myeloma (MM): Are They Present At Diagnosis or Can Be Induced by Lenalidomide?

Sergio Matarraz, Bruno Paiva, Maria Victoria Mateos, María Diez-Campelo, MD, PhD, Estefania Perez, María-Belén Vidriales, Lucía López-Corral, Pilar Giraldo, Miguel T. Hernandez, Felipe de Arriba, Javier De La Rubia, Joan Bargay, Fernando Leal da Costa, Graça Esteves, Juan José Lahuerta, Laura Rosiñol, MD, Joan Blade, Jesus F. San Miguel, MD, PhD, Alberto Orfao, MD, PhD

Blood (2011) 118 (21): 5066.

https://doi.org/10.1182/blood.V118.21.5066.5066

Published: 2011

Journal Articles

Multiparameter Flow Cytometry Analysis of Peripheral Blood T, NK and Dendritic Cells From High-Risk Smoldering Multiple Myeloma Patients Treated with Lenalidomide and Dexamethasone

Bruno Paiva, Lucía López-Corral, María-Belén Vidriales, Luis Ignacio Sánchez Abarca, Miguel T. Hernandez, Joan Bargay, Javier De La Rubia, Pilar Giraldo, Ana-Isabel Teruel, Laura Rosiñol, Albert Oriol, Jose Hernández, Felipe de Arriba, Graça Esteves, Jose Antonio Pérez Simón, María-Victoria Mateos, Jesus F San Miguel

Blood (2010) 116 (21): 1906.

https://doi.org/10.1182/blood.V116.21.1906.1906

Published: 2010

Journal Articles

Fluorescence In Situ Hybridization (FISH) Analysis In 160 Patients with IgM Monoclonal Gammopathies

Norma C. Gutierrez, Roberto JP Magalhaes, Ramón García-Sanz, María-Belén Vidriales, Enrique M. Ocio, Bruno Paiva, Daniel del Carpio, Alvaro Caballero, Jennifer Alonso, Lucia Lopez-Anglada, Teresa Villaescusa, Jesus M. Hernandez Rivas, A. Aguilar, Alejandro Martín, R. Lopez, Alberto Orfao, Jesus F San Miguel

Blood (2010) 116 (21): 1916.

https://doi.org/10.1182/blood.V116.21.1916.1916

Published: 2010

Journal Articles

Competition Between (Mono)Clonal Plasma Cells and Normal Cells for Potentially Overlapping Bone Marrow Niches Is Associated with a Progressively Altered Cellular Distribution In MGUS Vs. Myeloma

Blood (2010) 116 (21): 617.

https://doi.org/10.1182/blood.V116.21.617.617

Published: 2010

Journal Articles

Utility of Multiparameter Flow Cytometry Immunophenotypic Studies In Patients with Systemic Light Chain (AL) Amyloidosis

Bruno Paiva, María-Belén Vidriales, Jose J. Perez, Maria-Consuelo López-Berges, Ramón García-Sanz, Enrique M. Ocio, Rebeca Garcia, Alfonso Garcia de Coca, Emilia Pardal, Magdalena Sierra, Jose Hernández, Natalia de las Heras, Josefina Galende, Jose Maria Alonso, Abelardo Bárez, María-Victoria Mateos, Jesus F San Miguel

Blood (2010) 116 (21): 4051.

https://doi.org/10.1182/blood.V116.21.4051.4051

Published: 2010

Journal Articles

Analysis of Immunophenotypic Response (IR) by Multiparameter Flow Cytometry In 516 Myeloma Patients Included In Three Consecutive Spanish Trials

Blood (2010) 116 (21): 1910.

https://doi.org/10.1182/blood.V116.21.1910.1910

Published: 2010

Journal Articles

Clinical Outcome According to Both Cytogenetic Abnormalities (CA) Detected by Fluorescence In Situ Hibridization (FISH) and Hyperdiploidy Assessed by Flow Cytometry (FCM) In Elderly Newly Diagnosed Myeloma Patients Treated with A Bortezomib-Based Combination

Blood (2010) 116 (21): 309.

https://doi.org/10.1182/blood.V116.21.309.309

Published: 2010

Journal Articles

Value of Gene Expression Profiling by Taqman® Low Density Arrays in the Diagnosis and Prognosis of Acute Myeloid Leukemia.

Carmen Chillon, Carlos Santamaria, Ramon Garcia-Sanz, Montserrat Hernandez, Norma C. Gutiérrez, Dolores Caballero, Maria-Belén Vidriales, Cristina Pérez, Ana Balanzategui, Miguel Alcoceba, Maria E. Sarasquete, Noemi Puig, Fernando Ramos, Alfonso García de Coca, Joaquin Díaz-Mediavilla, J.F San Miguel, Marcos Gonzalez

Blood (2009) 114 (22): 1620.

https://doi.org/10.1182/blood.V114.22.1620.1620

Published: 2009

Journal Articles

Zalypsis Possess Potent Antileukemic Effect through the Induction of a DNA Damage Response, Independently of the p53 Status.

Enrique Colado, Teresa Paíno, Enrique M Ocio, Patricia Maiso, Xi Chen, Stela Álvarez-Fernández, Jesús Martín-Sánchez, Lorena González, Laura San-Segundo, Mercedes Garayoa, Diego Fernández-Lázaro, Maria-Belén Vidriales, Carlos Galmarini, Pablo Avilés, Carmen Cuevas, Atanasio Pandiella, Jesús F. San-Miguel, MD, PhD

Blood (2009) 114 (22): 3792.

https://doi.org/10.1182/blood.V114.22.3792.3792

Published: 2009

Journal Articles

A Phase I/II, National, Multicenter, Open Label Study of Bortezomib (Velcade) and Fludarabine, Cytarabine and Idarubicin (Flag-Ida) (V-Flag-Ida) in Pts with Relapsed and/or Refractory Acute Myeloblastic Leukemia (AML).

Maria-Victoria Mateos, Rafael Martínez, Salut Brunet, Maria-Belén Vidriales, Albert Oriol, MD, Juan José Lahuerta, MD, PhD, Mari Luz Amigo, Jordi Esteve, Javier de la Rubia, Luis Palomera, Javier Bueno, Jesus F San Miguel

Blood (2009) 114 (22): 4140.

https://doi.org/10.1182/blood.V114.22.4140.4140

Published: 2009

Journal Articles

Multiparameter Flow Cytometry Remission Is the Most Relevant Prognostic Factor for Multiple Myeloma Patients Who Undergo Autologous Stem Cell Transplantation

Blood (2008) 112 (11): 737.

https://doi.org/10.1182/blood.V112.11.737.737

Published: 2008

NARROW

Immunophenotypic Characteristics of CD34+ Cells According to Genetic Markers in Acute Myeloid Leukemias with Normal Karyotype.

Phenotypic, Functional and Circadian Characterization of Peripheral Blood (PB) Multiple Myeloma (MM) Circulating Tumor Cells (CTCs)

Multiparameter Flow Cytometry (MFC) for Identification of the Waldenström's Clone in IgM MGUS and Waldenstrom's Macroglobulinemia (WM): New Criteria for Differential Diagnosis and Risk Stratification

Whole Bone Marrow (BM) Immunophenotypic Profiling for the Identification of Newly Diagnosed Symptomatic Multiple Myeloma (MM) Patients with an MGUS-Like Signature Associated with Long-Term Disease Control (LTDC)

Multiparameter Flow Cytometry (MFC) Evaluation of Plasma Cell (PC) DNA Ploidy Status and Proliferative Rate in 595 Multiple Myeloma (MM) Patients (pts) Included in the Spanish GEM2000 and GEM2005<65years Trials: Clinical Value and Biological Insights,

Influence of Lenalidomide Treatment on Immune Effector Cells From High-Risk Smoldering Multiple Myeloma (SMM) Patients,

High-Risk Cytogenetics and Persistent Minimal Residual Disease (MRD) by Multiparameter Flow Cytometry (MFC) Predict Unsustained Complete Response (CR) After Autologous Stem Cell Transplantation (ASCT) in Multiple Myeloma (MM)

Multidimensional Flow Cytometric (MFC) Analysis of the Immune System of Multiple Myeloma (MM) Patients Achieving Long Term Disease Control

Biological and Clinical Significance of CD81 Expression by Clonal Plasma Cells in High-Risk Smoldering and Symptomatic Multiple Myeloma (MM) Patients,

Myelodysplasia-Associated Immunophenotypic Abnormalities of Bone Marrow (BM) Cells in Multiple Myeloma (MM): Are They Present At Diagnosis or Can Be Induced by Lenalidomide?

Multiparameter Flow Cytometry Analysis of Peripheral Blood T, NK and Dendritic Cells From High-Risk Smoldering Multiple Myeloma Patients Treated with Lenalidomide and Dexamethasone

Fluorescence In Situ Hybridization (FISH) Analysis In 160 Patients with IgM Monoclonal Gammopathies

Competition Between (Mono)Clonal Plasma Cells and Normal Cells for Potentially Overlapping Bone Marrow Niches Is Associated with a Progressively Altered Cellular Distribution In MGUS Vs. Myeloma

Utility of Multiparameter Flow Cytometry Immunophenotypic Studies In Patients with Systemic Light Chain (AL) Amyloidosis

Analysis of Immunophenotypic Response (IR) by Multiparameter Flow Cytometry In 516 Myeloma Patients Included In Three Consecutive Spanish Trials

Clinical Outcome According to Both Cytogenetic Abnormalities (CA) Detected by Fluorescence In Situ Hibridization (FISH) and Hyperdiploidy Assessed by Flow Cytometry (FCM) In Elderly Newly Diagnosed Myeloma Patients Treated with A Bortezomib-Based Combination

Value of Gene Expression Profiling by Taqman® Low Density Arrays in the Diagnosis and Prognosis of Acute Myeloid Leukemia.

Zalypsis Possess Potent Antileukemic Effect through the Induction of a DNA Damage Response, Independently of the p53 Status.

A Phase I/II, National, Multicenter, Open Label Study of Bortezomib (Velcade) and Fludarabine, Cytarabine and Idarubicin (Flag-Ida) (V-Flag-Ida) in Pts with Relapsed and/or Refractory Acute Myeloblastic Leukemia (AML).

Multiparameter Flow Cytometry Remission Is the Most Relevant Prognostic Factor for Multiple Myeloma Patients Who Undergo Autologous Stem Cell Transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only